Bacterias sticky glue may pave way for superbug vaccineSeptember 10th, 2008 - 2:24 pm ICT by ANI
Washington, Sept 10 (ANI): The sticky glue secreted by the bacterium Staphylococcus aureus may hold the key for making an effective vaccine against MRSA (Methicillin-resistant Staphylococcus aureus), according to a new study.
While Staphylococcus aureus stay as a biofilm fairly harmlessly on most of the people who carry the bacteria, it may rarely cause severe and life threatening infections that are significant medical problems.
Many of these infections are made worse by the biofilm component of the overall disease, which helps to protect the bacteria from antibiotics.
“If individuals get infections many times, even after they have been cured by antibiotics, it indicates that their bodies have not become immune to Staph bacteria,” said Professor Gerald Pier from Harvard Medical School in Boston, USA.
Staph bacteria tend to grow in cellular communities, particularly on medical devices commonly used on patients, like catheters, artificial heart valves, knees and hips, producing what are called biofilm type infections. All patients with these types of devices in them have an increased risk for Staph infections. Living in biofilms protects the bacteria from antibiotics, making treatment more difficult.
“To grow as a biofilm the bacteria must produce sticky factors, one of which is a type of complex sugar called PNAG. We are targeting this material as a possible vaccine, but natural exposure to the sugar compound does not result in most people and animals making an immune response that would protect them from attack by the bacteria or recurring infections,” said Pier.
The scientists have manipulated the sugar chemically to discover that they can produce variant forms, which can be used as vaccines by causing the right type of immune response.
This approach has already been shown to work successfully in animal studies.
“We now have a way to tip the balance for resistance to infection back towards humans by vaccination. It is most likely that one or more forms of the vaccine will be prepared to test in humans to see which form is best to get the most desirable antibodies made,” said Pier.
Besides, the scientists have also created an antibody with the desired properties to give to people if they have a high risk of getting a Staph infection, thus preventing infection.
“This antibody is being manufactured to start tests in humans in about 12 to 18 months. An effective antibody treatment for Staph infections could have a major benefit for anyone who enters a hospital or works in the community and is at risk of Staph infections,” said Pier.
The study was presented at the Society for General Microbiology’’s Autumn meeting being held this week at Trinity College, Dublin. (ANI)
- Immunity boosting vitamin can fight superbugs - Aug 28, 2012
- Scientists one step closer to developing vaccine for MRSA - Jan 17, 2011
- How pathogenic bacteria hide inside host cells - Jan 27, 2011
- Cranberry juice can block Staph infections - Sep 02, 2010
- Soon, cold plasma jets to replace antibiotics - Dec 16, 2010
- 'Staph' bacteria prefer the taste of human blood - Dec 16, 2010
- Honey can help reverse bacterial resistance to antibiotics - Apr 13, 2011
- Nutrition-starved bugs become resistant to antibiotics - Nov 18, 2011
- Scientists trick bacteria to incorporate foreign small molecules into cell wall - Oct 09, 2010
- Infectious bugs alter DNA to become resistant - Nov 14, 2011
- Chemical compound effective in destroying antibiotic-resistant biofilms - Apr 09, 2010
- Immune system's strong response to toxins can makes us ill - Nov 29, 2010
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Blocking bacteria's 'death signal' could treat severe bone disease - Sep 07, 2010
- New strain of killer E. coli decoded - Jul 27, 2012
Tags: animal studies, antibiotics, artificial heart valves, bacterium staphylococcus aureus, biofilm, boston usa, catheters, harvard medical school, immune response, medical devices, medical problems, methicillin resistant staphylococcus, methicillin resistant staphylococcus aureus, natural exposure, professor gerald, resistant staphylococcus aureus, staph bacteria, staph infections, sticky glue, sugar compound